• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERA II DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERA II DUODENOVIDEOSCOPE Back to Search Results
Model Number TJF-Q180V
Device Problem Microbial Contamination of Device (2303)
Patient Problem Unspecified Infection (1930)
Event Date 07/02/2020
Event Type  Injury  
Manufacturer Narrative
The equipment was reprocessed for possible contamination of the patient.Additional event information has been requested but not received.The device was not returned to olympus for evaluation.The cause of the reported event cannot be determined.If additional information becomes available at a later time, this report will be supplemented.
 
Event Description
It was reported the patient underwent an endoscopic ultrasound (eus) and endoscopic retrograde cholangiopancreatography (ercp) on (b)(6) 2020 during which the gf-uct180 and the tjf-q180v duodenoscope were used.Non-frank hilar stenosis and incomplete drainage of contrast medium was identified.Subsequently, a second ercp was performed on (b)(6) 2020 using the tjf-q180v duodenoscope.During the procedure a 8 mm x 40 mm self-expanding metallic biliary prosthesis was placed to covered in the right liver branch, unable to drain the left liver branch, presenting after the procedure severe cholangitis in the patient, the pseudomonas aeruginosa was isolated on (b)(6) 2020.
 
Manufacturer Narrative
This supplemental report is being submitted to provide additional information received from the customer, the device history record review (dhr), legal manufacturer's investigation, and a correction to the initial report.Correction: aware date (b)(6) 2020 for e1.The customer also reported: it is unknown what cleaning and disinfectant solutions were used with the endoscope.It is unknown how off the minimum effective concentration is being checked.It is unknown what type of aer is being used to reprocess the endoscopes.It is unknown if the endoscope channel is being brushed during manual cleaning.The scope was pre-cleaned immediately after the procedure by following the cleaning process.The scope was not being leak tested prior to the manual cleaning.No problems were noted with the automated endoscope reprocessors (aers).There was no flushing or air into the endoscope channel after reprocessing.Site received a reprocessing in-service august 2020.The site did not have a change in the reprocessing personal from the time the in-service occurred to when the issue happened.All reprocessing personnel are properly trained on how to reprocess and endoscope.The site does not wish to have an endoscopy support specialist conduct a site visit for another reprocessing in-service.Scope storage - delivered to client.The dhr for this device were reviewed and all records indicated the product was manufactured according to all applicable procedures and met final product release criteria.No abnormalities were found.A definitive root cause was not identified.Based on the available information, the legal manufacturer could not determine the relationship between the patient's positive culture and the subject device.The subject device was not culture tested.
 
Event Description
Additional information received from customer: there was a procedural delay of an unknown length of time.The patient was treated for the infection, however treatment course is unknown.No defects detected with devices.Scope not cultured.
 
Manufacturer Narrative
This supplemental report is being submitted to provide the additional information received from the customer.The following field was updated: b5.Procedure date corrected to (b)(6) 2021.
 
Event Description
Additional information from customer: the procedure was performed on (b)(6) 2021.The procedural delay was due to the incomplete draining of the left hepatic branch.The patient is reported to be "recovered" and the biliary prosthesis was removed (b)(6) 2020.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA II DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA  192-8507
MDR Report Key10381831
MDR Text Key202261940
Report Number8010047-2020-05390
Device Sequence Number1
Product Code FDT
UDI-Device Identifier04953170367311
UDI-Public04953170367311
Combination Product (y/n)N
PMA/PMN Number
K143153
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 10/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberTJF-Q180V
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/14/2020
Initial Date FDA Received08/07/2020
Supplement Dates Manufacturer Received08/25/2021
09/28/2021
Supplement Dates FDA Received09/21/2021
10/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-